Edward Mathers is a Partner at NEA focused on healthcare, biotechnology, and specialty pharmaceuticals. He joined NEA in 2008 after roles at MedImmune, Inhale Therapeutic Systems, and Glaxo Wellcome.
At firms with a similar stage, sector and check size.
One email when Edward's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckEdward Mathers is a Partner at NEA focused on healthcare, biotechnology, and specialty pharmaceuticals. He joined NEA in 2008 after roles at MedImmune, Inhale Therapeutic Systems, and Glaxo Wellcome.
Edward Mathers invests through New Enterprise Associates (NEA), which writes checks of $1M to $30M+ at pre-seed, seed, series a, series b.
A warm intro from a founder New Enterprise Associates (NEA) backed works best.
sales and marketing positions at Glaxo Wellcome (now GSK); VP of Marketing and Corporate Licensing and Acquisitions at Inhale Therapeutic Systems; EVP of Corporate Development and Venture at MedImmune; Glaxo Wellcome; Partner at NEA.
Last updated 2026-10-15. Is this you? Ask for a correction.